PLA2G4B Antikörper
Kurzübersicht für PLA2G4B Antikörper (ABIN7117477)
Target
Alle PLA2G4B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- PLA2G4B antibody
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- phospholipase A2, group IVB(cytosolic)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:2000, IHC: 1:20-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months
-
Haltbarkeit
- 12 months
-
-
- PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))
-
Andere Bezeichnung
- PLA2G4B
-
Hintergrund
-
Synonyms: Cytosolic phospholipase A2 beta (cPLA2-beta)|Lysophospholipase A1 group IVB|Phospholipase A2 group IVB|PLA2G4B
Background: PLA2G4B, also named as cPLA2-beta, is a member of the cytosolic phospholipase A2 protein family. It is calcium-dependent phospholipase A2 that selectively hydrolyzes glycerophospholipids in the sn-2 position with a preference for arachidonoyl phospholipids. PLA2G4B has five isoforms with MW 88 kDa, 100 kDa, 55 kDa and 114 kDa.
-
Molekulargewicht
- 88 kDa, 114 kDa
-
Gen-ID
- 100137049
-
UniProt
- P0C869
-
Pathways
- ER-Nucleus Signaling, VEGF Signaling
Target
-